Mopidamol is a analogue of dipyridamole, is a phosphodiesterase inhibitor that has been shown previously to limit progression of malignancy in certain experimental animal models and in a pilot study in humans. References: Blaha H, Dierkesmann R, Feuerer W, Gatzemaier U, Geser C, Lemme J, Mall W, Ritscher R, Schneider B, Vallee D. [Adjuvant therapy of non-small cell bronchial cancer with mopidamol]. Pneumologie. 1989 Jun;43(6):299-304. German. PubMed PMID: 2547216.

纯度：≥98%

CAS：13665-88-8